IDARUCIZUMAB

Search structure
Trade Names:
Synonyms:
Status: Approved (2015)
Entry Type: Antibody
Molecule Category: UNKNOWN
ATC: V03AB37
UNII: 97RWB5S1U6

Pharmacology

Action Mechanism of Action Reference
SEQUESTERING AGENT Dabigatran sequestering agent DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hemorrhage 4 D006470 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Vascular disorders
29.17
Nervous system disorders
13.67
General disorders and administration site conditions
8.37
Gastrointestinal disorders
7.5
Injury, poisoning and procedural complications
7.0
Respiratory, thoracic and mediastinal disorders
6.4
Cardiac disorders
5.87
Infections and infestations
4.3
Investigations
4.2
Renal and urinary disorders
3.8
Metabolism and nutrition disorders
2.33

Cross References

Resources Reference
CAS NUMBER 1362509-93-0
ChEMBL CHEMBL3544996
FDA SRS 97RWB5S1U6
Guide to Pharmacology 8298
CONTENTS